Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments
Source abstract
Abstract
Abstract As a novel 2D material, black phosphorus (BP) nanosheets are considered as a promising candidate for drug delivery platform for synergistic chemo/photothermal therapy. However, the intrinsic instability of bare BP poses a challenge in its biomedical applications. To date, some strategies have been employed to prevent BP from rapid ambient degradation. Unfortunately, most of these strategies are not suitable for the drug delivery systems. Here, a simple polydopamine modification method is developed to enhance the stability and photothermal performance of bare BP nanosheets. Then, this nanocapsule is used as a multifunctional codelivery system for the targeted chemo, gene, and photothermal therapy against multidrug‐resistant cancer. The enhanced tumor therapy effect is demonstrated by both in vitro and in vivo studies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · 2D Materials and Applications · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences (Shenzhen) Sun Yat‐sen University Guangzhou 510275 China
Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA
Funding
National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province
References (47)
Show source-provided references
1. 10.1002/advs.20160043510.1002/advs.201600435 ↗
2. 10.1038/nnano.2014.8510.1038/nnano.2014.85 ↗
3. 10.1002/adma.20140515010.1002/adma.201405150 ↗
4. 10.1039/C4CC05752J10.1039/C4CC05752J ↗
5. 10.1002/smll.20170066110.1002/smll.201700661 ↗
6. 10.1002/anie.20170572210.1002/anie.201705722 ↗
7. 10.1021/nn501226z10.1021/nn501226z ↗
8. 10.1039/C4CS00257A10.1039/C4CS00257A ↗
9. 10.1038/ncomms1296710.1038/ncomms12967 ↗
10. 10.1016/j.biomaterials.2016.03.02210.1016/j.biomaterials.2016.03.022 ↗
11. 10.1002/adma.20160327610.1002/adma.201603276 ↗
12. 10.1073/pnas.141658111210.1073/pnas.1416581112 ↗
13. 10.1002/adma.20160386410.1002/adma.201603864 ↗
14. 10.1002/anie.20151203810.1002/anie.201512038 ↗
15. 10.1038/nmat429910.1038/nmat4299 ↗
16. 10.1038/nchem.250510.1038/nchem.2505 ↗
17. 10.1021/nl503229310.1021/nl5032293 ↗
18. 10.1002/adma.20170381110.1002/adma.201703811 ↗
19. 10.1126/science.114724110.1126/science.1147241 ↗
20. 10.1021/cr400407a10.1021/cr400407a ↗
21. 10.1021/am501391z10.1021/am501391z ↗
22. 10.1016/j.actbio.2016.10.01010.1016/j.actbio.2016.10.010 ↗
23. 10.1002/adma.20120468310.1002/adma.201204683 ↗
24. 10.1016/j.biomaterials.2016.10.05310.1016/j.biomaterials.2016.10.053 ↗
25. 10.1002/advs.20170005810.1002/advs.201700058 ↗
26. 10.1002/advs.20160012210.1002/advs.201600122 ↗
27. 10.1146/annurev.med.56.062904.14491510.1146/annurev.med.56.062904.144915 ↗
28. 10.1016/j.biomaterials.2017.08.03010.1016/j.biomaterials.2017.08.030 ↗
29. 10.7150/thno.2134210.7150/thno.21342 ↗
30. 10.7150/thno.1418410.7150/thno.14184 ↗
31. 10.1158/0008-5472.CAN-07-572310.1158/0008-5472.CAN-07-5723 ↗
32. 10.1016/j.biomaterials.2011.09.02310.1016/j.biomaterials.2011.09.023 ↗
33. 10.1002/adfm.20170413510.1002/adfm.201704135 ↗
34. 10.1039/C7NR05450E10.1039/C7NR05450E ↗
35. 10.3390/cancers603176910.3390/cancers6031769 ↗
36. 10.1002/advs.20160004610.1002/advs.201600046 ↗
37. 10.1021/acsami.7b0245710.1021/acsami.7b02457 ↗
38. 10.1039/C4TA06871H10.1039/C4TA06871H ↗
39. 10.1016/j.apsusc.2015.09.17110.1016/j.apsusc.2015.09.171 ↗
40. 10.1002/anie.20140494710.1002/anie.201404947 ↗
41. 10.1002/anie.20150615410.1002/anie.201506154 ↗
42. 10.1002/adhm.20140067610.1002/adhm.201400676 ↗
43. 10.1021/ja312221g10.1021/ja312221g ↗
44. 10.1016/j.actbio.2013.08.01510.1016/j.actbio.2013.08.015 ↗
45. 10.1016/j.biomaterials.2017.01.00110.1016/j.biomaterials.2017.01.001 ↗
46. 10.1016/j.biomaterials.2016.05.05610.1016/j.biomaterials.2016.05.056 ↗
47. 10.1039/C7NR05450E10.1039/C7NR05450E ↗